Why Zoho's Sridhar Vembu believes AI models can’t yet match human creativity

Why Zoho's Sridhar Vembu believes AI models can’t yet match human creativity

Sridhar Vembu, the co-founder and chief scientist of Zoho, has recently shared his insights on the limitations of artificial intelligence in the realm of creativity. In a post on X, he emphasized that genuine creative endeavors occur 'out of the training distribution,' a space where large language models (LLMs) often fall short. Vembu pointed out that while AI systems, particularly chess and Go engines, can generate innovative moves, they operate on fundamentally different principles than contemporary LLMs. He stated, "True creative work is ‘out of the training distribution’ work. Chess or Go engines do come up with creative moves. The foundational approach they use, Monte Carlo Tree Search, is different from how LLMs work, which may explain why LLMs don’t perform well outside their training distribution." In his analysis, Vembu contrasted the structured environments of games, which have clear rules that differentiate valid from invalid moves, with the chaotic nature of the real world. He remarked, "Games have precise rules of the game, valid vs invalid moves, etc. The real world is much more messy." He also noted that software code shares similarities with games and suggested that techniques from gaming engines could be beneficial in this field. Vembu's comments have become part of a larger conversation within the technology sector about the constraints of current AI models, especially when it comes to tasks that require innovative thinking or reasoning beyond their programmed data. Adding to the controversy, he recently shared a paper on X that controversially stated vaccination is the 'dominant risk factor' for autism. He urged parents to heed this analysis, claiming, "There is increasing evidence that we are giving way too many vaccines to very young children," and noted a rising trend in autism cases in India. These statements have sparked significant backlash from medical professionals, including Dr. Philips, an acclaimed hepatologist known for his fight against medical misinformation. He criticized Vembu's claims, highlighting the lack of scientific rigor in the paper and its authors' ties to anti-vaccine movements. Dr. Philips noted, "The so-called ‘authors’ are known anti-vaccine activists funded by an anti-vaccine organization. The study was published on their own website and has not undergone any peer review or independent scientific scrutiny."

Sources : Mint

Published On : Nov 02, 2025, 09:40

Startups
Innovative Startup Aims to Combat Copper Shortage with Microbial Boosts

The looming copper shortage, projected to hit critical levels by 2040, has raised alarms across various industries, incl...

TechCrunch | Jan 15, 2026, 16:40
Innovative Startup Aims to Combat Copper Shortage with Microbial Boosts
Cybersecurity
New Bluetooth Vulnerability Exposes Headphones to Eavesdropping Threat

Bluetooth connections are often seen as convenient, but a recent discovery is raising alarms about their security. Resea...

Ars Technica | Jan 15, 2026, 17:50
New Bluetooth Vulnerability Exposes Headphones to Eavesdropping Threat
AI
Wikimedia Foundation Celebrates 25 Years with Major AI Partnerships

In a momentous celebration of its 25th anniversary, the Wikimedia Foundation has unveiled a series of new collaborations...

TechCrunch | Jan 15, 2026, 16:00
Wikimedia Foundation Celebrates 25 Years with Major AI Partnerships
Startups
OpenAI Backs Sam Altman's New Brain-Computer Interface Venture

In an intriguing development within the tech industry, OpenAI has made a significant investment in Merge Labs, a brain-c...

TechCrunch | Jan 15, 2026, 17:05
OpenAI Backs Sam Altman's New Brain-Computer Interface Venture
Startups
Amazon Takes Aim at Saks Bankruptcy Financing Amid $475M Stake Concerns

Amazon is urging a federal judge to reject the bankruptcy financing plan proposed by Saks Global, arguing that the depar...

CNBC | Jan 15, 2026, 16:45
Amazon Takes Aim at Saks Bankruptcy Financing Amid $475M Stake Concerns
View All News